New Marketplace

From Health Care Provider to Payer: One Executive’s Perspective

Interview · February 2, 2016

After decades in academic medicine and management, Harold Paz, MD, MS, left his position as chief executive officer of the Penn State Hershey Medical Center and Health System in 2014 to become chief medical officer and executive vice president at Aetna.

He sat down with NEJM Catalyst’s Thomas Lee, MD, to talk about the perspective he has gained in his new role.

Thomas Lee: What’s different about your new place in the health care system compared to where you were in the past?

Harold Paz: Clearly, there are some real differences. In terms of my role, I left being CEO of a large health system and medical center and dean of a medical school. I held these types of responsibilities for around 20 years; prior to being at Penn State, I was dean of Robert Wood Johnson Medical School and CEO of the medical group there.

The role of chief medical officer [at a health insurance company] is a different role, but it’s one of tremendous opportunity to focus on strategy, quality, and medical policy, through the lens of scientific and clinical data. It is an exciting time to think about ways to create an innovative health experience for all of our members.

Clearly, the roots and origins of Aetna are in insurance — it is for-profit, and this is the first time I’ve worked for a public company. But there are many remarkable similarities. Aetna is committed to the same mission we had when I was leading Penn State’s health system, which is to build a healthier world. One of the reasons I made the move is that I think there are enormous opportunities to form collaborations, partnerships, and new organizational structures between physicians and hospitals, and payers.

The world is evolving such that these relationships will continue to grow and succeed as we move toward value-based health care design and reimbursement structures away from fee-for-service medicine. I think there are going to be unique opportunities for a company like Aetna to better enable physicians address the health status of their patients and the communities in which they live and work.

Lee: What strategic advice would you give to those leading health care delivery systems?

Paz: The most interesting thing about making the move from running a large health system to joining Aetna is the opportunity I’ve had to work on new technologies and approaches to care that are developing through innovation. Aetna Clinical Innovation and new start-up companies are offering new ideas that are quite different than the traditional approach to patient care delivery and even the traditional the doctor / patient relationship.

With the influx of big data, new technologies, personalized medicine, the emphasis on community-based care, and understanding how determinants of health impact health status, we will see a rapid transformation in the U.S. and globally in health care delivery overall. Frankly, at times, working in a traditional health care setting, it is possible to miss how these emerging technologies and approaches are going to radically change the way care is delivered.

Further driving this will be worsening shortages of clinicians along with an aging population and increased burden of chronic disease with population growth. All these factors will exacerbate already limited access to care — and will ironically open the door to other approaches of care delivery that we’re only beginning to appreciate and understand.

Lee: What does it take for health care mergers to produce value in the marketplace?

Paz: Without a doubt, health care in America is moving from what Paul Starr described years ago in his book, The Social Transformation of American Medicine, as a cottage industry to something very different, and it clearly parallels what’s happened in other industries in this country. Frankly, that’s not surprising. I think our focus has to be how we can take a multidimensional view of improving health and health status in our communities, and it has to be done by looking at all five determinants of health.

Health care is obviously a critical one. But social determinants of health, socioeconomic status, genomics, the environment, are all important. They all come together within communities and affect each individual patient in multiple different ways. The inevitable benefit of all the changes we’re seeing, both on the payer’s side and the provider’s side, are new and innovative models of care delivery focused on populations and communities where payers and providers work collaboratively to improve access and quality and eliminate waste in the system. Of the three trillion dollars that we spend on health care in this country — which is just one of those determinants of health status — roughly one-third, by most estimates, goes to waste. If we can find ways to repurpose and reinvest that trillion dollars into improving health care, everybody’s a winner.

Lee: Do you have any particular advice for leaders of academic medical centers?

Paz: First and foremost, focus on training the next generation of physicians, nurses, and other health care clinicians in ways to be successful as health care evolves and continues to change in this country. When we give someone a medical degree, the education and training has to be durable so that that individual is successful for many, many years to come. It’s everyone’s responsibility to make sure that these individuals have the ability to provide outstanding care as the relationship between doctors and patients evolves, and as we move toward a more patient-centric universe.

Finally, we must address the opportunities around access to care and quality of care while finding ways to reduce the cost of care. Until we are able to successfully address the issue of affordability, it will remain a burden not only to our patients but also for our nation as a whole.

New call for submissions ­to NEJM Catalyst

Now inviting longform articles

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

More From New Marketplace
Three-Part Pricing of PCSK9 Inhibitors

A New Model for Pricing Drugs of Uncertain Efficacy

Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.

what does quality measurement in health care mean

Buzz Survey Report: Addressing the Problems of Quality Measurement

An independent NEJM Catalyst report sponsored by University of Utah Health on patient involvement in quality measurement.

Average HOOS and Average KOOS for patients undergoing hip and knee replacement at CJRI

Building a “Hospital-within-Hospital” Model for Joint Replacements

The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on a common vision to yield drastic improvements in quality, safety, and costs.

Discharge Rates and Follow-Up Internval Dashboard for One Provider at MGH Dermatology

A Successful Pilot to Improve Access by Adjusting Discharge and Follow-Up Rates

Actionable data and modest financial incentives can help motivate clinicians to adjust their behavior around scheduling follow-up appointments.

Cautious Optimism That Value-Based Reimbursement Will Become Primary Revenue Model

Survey Snapshot: What Would Accelerate the Adoption of Value-Based Care?

NEJM Catalyst Insights Council members weigh in on the barriers and path forward to value-based health care.

Strongwater08_pullquote primary care value proposition and disruptive innovation

The Evolution of Primary Care: Embracing Innovation While Protecting the Core Value

Primary care must leverage disruptive innovations to ensure that patients receive first-access, comprehensive, coordinated, continuous care that is woven into a seamlessly integrated system.

Berns01_pullquote nephrologists dialysis facility joint venture conflicts of interest

Dialysis-Facility Joint-Venture Ownership — Hidden Conflicts of Interest

Despite potential benefits, joint ventures between nephrologists and dialysis companies raise legal and ethical concerns because of participants’ conflicts of interest and lack of transparency.

Fee-for-Service Continues to Account for the Majority of Revenue

New Marketplace Survey: Transitioning Payment Models: Fee-for-Service to Value-Based Care

In a survey of the NEJM Catalyst Insights Council sponsored by Optum, respondents express enthusiasm for value-based care but have conflicting opinions about just how far along that path they should go.

Sample Report Comparing Individual Patient-Reported Outcome Measures with FORCE-TJR National Norms

The Essential Role of Patient-Centered Registries in an Era of Electronic Health Records

Smartly designed patient-centered registries capture longitudinal data to augment EHRs and enhance quality improvement, policy, and research efforts.

Murray02_pullquote surgical care bundled payments accountable care organizations

Surgical Value — Beyond Bundled Payments

The surgeon has a crucial role in defining value for patients in a population — and not just when that patient is in need of the surgeon’s knife.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Value Based Care

194 Articles

A New Model for Pricing Drugs…

Are we paying too much for new drugs before we know how well they work?…

A Venn Diagram for Health Care…

A simple road map for health care organizations to follow when working through integration, which…

A Venn Diagram for Health Care…

A simple road map for health care organizations to follow when working through integration, which…

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now